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The vaccinia virus I3L gene encodes a single-stranded DNA binding protein (SSB) that is essential for virus
DNA replication and is conserved in all Chordopoxviruses. The I3 protein contains a negatively charged C-
terminal tail that is a common feature of SSBs. Such acidic tails are critical for SSB-dependent replication,
recombination and repair. We cloned and puriﬁed variants of the I3 protein, along with a homolog from
molluscum contagiosum virus, and tested how the acidic tail affected DNA–protein interactions. Deleting
the C terminus of I3 enhanced the afﬁnity for single-stranded DNA cellulose and gel shift analyses
showed that it also altered the migration of I3-DNA complexes in agarose gels. Microinjecting an anti-
body against I3 into vaccinia-infected cells also selectively inhibited virus replication. We suggest that
this domain promotes cooperative binding of I3 to DNA in a way that would maintain an open DNA
conﬁguration around a replication site.
& 2016 Elsevier Inc. All rights reserved.Introduction
Poxviruses are large DNA viruses that replicate in discrete
cytoplasmic foci, or factories. The prototypical poxvirus, vaccinia
virus (VACV), encodes most of its own proteins required for DNA
replication. These include a DNA polymerase (E9) which associates
with two additional proteins (A20þD4) in a trimeric complex
(Stanitsa et al., 2006), a primase/helicase (D5) (De Silva et al.,
2007), a DNA ligase (A50) (Kerr and Smith, 1991), enzymes cata-
lyzing dNTP biogenesis (J2, F2, F4/I4, A48R) (Beaud, 1995; Gam-
mon et al., 2010; Weir and Moss, 1983), a Holiday junction resol-
vase (A22) (Garcia et al., 2000), a single-stranded DNA binding
protein (I3) (Rochester and Traktman, 1998; Tseng et al., 1999), a
ﬂap endonuclease (G5) (Senkevich et al., 2009), and other proteins
of less certain function such as H5 (Boyle et al., 2015; Kay et al.,
2013). Replication is also linked to virus recombination and uses a
single-strand annealing reaction catalyzed by E9 and I3 (Gammon
and Evans, 2009; Willer et al., 2000).
Several models have been proposed to explain the mechanism
of poxvirus DNA replication with a “rolling hairpin” mechanism
being long favored as a way of explaining the origins of con-
catemeric replication intermediates (Moyer and Graves, 1981).
However, this model does not explain why VACV encodes a proteinbiology & Immunology, 6020
AB, Canada T6G 2E1.with DNA primase activity (De Silva et al., 2007). The fact that
VACV encodes a primase as well as a ﬂap endonuclease (Senkevich
et al., 2009) suggests that it could also use a discontinuous mode
of DNA replication requiring leading and lagging strand DNA
synthesis.
Although these matters remain to be resolved, it is well
established that single-stranded DNA (ssDNA) substrates are cri-
tical replication, recombination, and repair intermediates and
ssDNA is always sequestered in complexes composed of the DNA
plus single-strand DNA binding proteins (SSBs). VACV also encodes
a SSB, called I3, encoded by the I3L gene (Rochester and Traktman,
1998). I3 is an essential gene product that exhibits early and
intermediate expression kinetics, binds with high afﬁnity to
ssDNA, and localizes to factories (Rochester and Traktman, 1998;
Welsch et al., 2003). S1 protection and gel-shift assays have
detected at least two DNA binding sites (9 and 31 nt) and gel
shift assays combined with protein titrations suggest that different
structures are formed at different DNA-to-protein ratios (Tseng et
al., 1999). Electron microscopy showed that compact DNA–protein
complexes with a “beads on a string” appearance are formed at
low protein densities, which are converted to more linear struc-
tures as the protein loading is increased (Tseng et al., 1999). The
capacity to form such protein multimers seems to be essential for
biological activity (Greseth et al., 2012). Although the gene cannot
be disrupted, RNA interference shows that I3 is needed for both
virus replication and recombination in vivo (Gammon and Evans,
2009; Greseth et al., 2012).
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ferent DNA-binding modes exhibited by other SSBs even though
there are no obvious similarities between poxviral and other
bacterial, viral, or phage SSBs. Moreover, I3 encodes a patch of
40 negatively charged residues at the C-terminus, a feature that
is characteristic of many phage and bacterial SSBs and which
serves several different functions. For example, the T4 bacter-
iophage GP32 protein also encodes a 46 aa acidic C-terminal tail.
The tail can be excised by limited proteolysis to create a form
called GP32*I, which binds more tightly to ssDNA than the native
protein and acquires the capacity to melt duplex DNA (Lonberg
et al., 1981; Moise and Hosoda, 1976). When DNA binds to native
GP32, it displaces the C-terminus fromwhere it occludes the DNA-
binding cleft, and the displaced and exposed end can then serve as
a binding site for other proteins (Kowalczykowski et al., 1981;Fig. 1. Poxvirus single-strand binding proteins and the clones used in this study. Panel
viruses representing other principle Chordopoxviruses. The asterisks (*) show trypsin hy
shows the sequences deleted from two sub-clones of the VACV I3L and molluscum conta
two proteins. Panel B shows the puriﬁed recombinant proteins used in these studies, ana
migrates in SDS-PAGE gels at 35 kDa (Tseng et al., 1999). Native MCV 046 protein (3
monoclonal antibody 10D11 determined by western blotting. It recognized an epitope dKrassa et al., 1991; Lonberg et al., 1981). Interestingly, the
C-terminus of GP32 is an immunodominant epitope (Krassa
et al., 1991), a feature that may also characterize I3.
Bacteriophage T7 GP2.5 exhibits similar properties. The acidic
C-terminus (26 aa) also encodes a critically important aromatic
amino acid residue and, if this domain and phenylalanine are
deleted, it disrupts GP2.5 binding to the T7 DNA polymerase/
thioredoxin complex and primase-helicase, as well as increasing
the afﬁnity of the truncated protein for ssDNA. Deleting the tail
also prevents GP2.5 dimer formation by interfering with a domain
swap interaction. A scheme very similar to the DNA binding and
C-terminal tail displacement model, originally proposed for T4
GP32, has been suggested to explain these features of T7 GP2.5 (He
et al., 2003; Hyland et al., 2003; Marintcheva et al., 2006, 2008).A shows an alignment of the vaccinia virus I3 protein with the homologs found in
persensitive sites that were previously mapped in I3 (Tseng, 2000). The ﬁgure also
giosum virus 046L genes. These encompass most of the acidic C-terminal tails of the
lyzed using SDS-PAGE. Note that although I3L encodes a 30 kDa protein, it generally
1.5 kDa) seems to exhibit the same property. Panel C illustrates the speciﬁcity of
eleted in form I31–244.
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ichia coli SSB encodes a highly conserved short C-terminal peptide
composed of acidic and hydrophobic residues. Like GP32 and
GP2.5, this element mediates interactions with many proteins
including those involved in DNA replication (e.g. the χ subunit of
polymerase III), recombination (e.g. RecQ), and repair (e.g. exo-
nuclease I and polymerase II) [reviewed in Shereda et al. (2008)].
Likewise, a 42–62 aa peptide encoding the C-terminus of E. coli
SSB is rendered more protease sensitive by DNA binding and
deleting the C-terminus enhances the helix-destabilizing activity
of the protein (Williams et al., 1983).
In contrast to these well characterized systems, little is known
about the purpose served by the acidic terminus of I3, beyond the
fact that it may also promote binding to the viral ribonucleoside
diphosphate reductase (Davis and Mathews, 1993). In this article
we explore how the I3 C-terminus affects ssDNA binding, protein–
protein interactions, and virus replication. Our results show that
the I3 C-terminus modulates DNA binding and homotypic inter-
actions in a manner similar to the role served by the same element
in bacterial and phage SSBs. However, we can ﬁnd no evidence
of a stable interaction with other proteins mediated by the I3
C-terminus.Fig. 2. Single-strand DNA binding properties of VACV and MCV SSBs. The indicated
proteins were bound to single-stranded calf thymus DNA cellulose resins and then
eluted with buffers containing increasing concentrations of NaCl. Each eluted
fraction was separated by SDS-PAGE and the amount of protein determined from
digital images of the Coomassie blue stained gels. The upper panel shows the
elution of native I3 (I31–270) versus the C-terminal truncated form (I31–244). The
midpoints of the elution curves are 0.44 and 0.71 M NaCl respectively. The lower
panel shows the behavior of the native and truncated forms of the MCV 046 pro-
tein, the native (0461–288) and 0461–265 forms eluted at 0.21 and 0.79 M NaCl
respectively.Results
Cloning of poxvirus SSB proteins
The PCR and different oligonucleotide primers were used to
prepare bacterial clones expressing a full-length (I31–270) and a
C-terminal truncated (I31–244) form of the VACV I3 SSB. The
deletion boundary was located on the C-terminal side of a small,
highly conserved “EED” motif, and causes the deletion of a 25-
residue peptide bearing 9 aspartic or glutamic acid residues
(Fig. 1A). The choice of this site as the deletion boundary was
based upon a previous study, where we treated full-length N- and
C-terminal tagged I3 with trypsin in the presence of ssDNA. Using
MALDI-TOF mass spectrometry we detected the rapid production
of three different large peptides, all sharing a common C-terminal
cleavage site at I3 residue R245 (Tseng, 2000). PCR was also used to
prepare full-length (0461–288) and truncated (0461–265) clones
encoding the MCV MC046L gene product. This strategy deletes a
similar 23-residue peptide bearing 7 acidic residues. All four
proteins were expressed in E. coli and puriﬁed to Z90% purity
using afﬁnity chromatography, as measured by SDS PAGE gels
(Fig. 1B). We tried to produce recombinant forms of more distantly
related Orf and fowlpox virus I3 homologs, but these expressed
too poorly in E. coli to be used (data not shown). We also used site-
directed mutagenesis to incorporate neutral and positive charged
residues in the I3 C-terminal tail, but bacterial proteases rapidly
converted these mutant forms of the full-length I3 protein into
smaller proteins resembling the I31–244 form in size (data not
shown).
As part of this study, we also pursued a number of crystal-
lization trials. A C-terminal his-tagged form of the VACV protein
(I315-244-his6) rapidly formed crystals in the presence or absence of
DNA, and under various buffer conditions. However, despite
extensive screening for better growth conditions, the crystals were
too disordered to permit further X-ray analysis.
Deletion of the C-terminal tail from I3 enhances its afﬁnity for ssDNA
Afﬁnity chromatography was used to test how deleting the
C-termini from the VACV and MCV proteins affected ssDNA binding.
The puriﬁed proteins were bound to ssDNA cellulose resin in a low
salt (50 mM) buffer and then eluted in a stepwise manner withincreasing amounts of NaCl. The amount of eluted protein was then
determined by imaging the stained protein on SDS PAGE gels. The
full length VACV I31–270 protein exhibited an “elution concentration
50%” (EC50) value of 0.44 M NaCl (95% c.i.¼0.3–0.6 M) whereas the
I31–244 form exhibited a signiﬁcantly higher afﬁnity for ssDNA with
the EC50¼0.71 M NaCl (95% c.i.¼0.7–0.8 M) (Fig. 2). This same
trend was observed with the MCV SSB. The full-length 0461–288 form
eluted at EC50¼0.21 M NaCl (95% c.i.¼0.1–0.3 M) whereas the trun-
cated 0461–265 form eluted at a 3-fold higher salt concentration
[EC50¼0.79 M NaCl (95% c.i.¼0.7–0.9 M)] (Fig. 2). Deleting the acidic
tail from two different Chordopoxvirus SSBs enhances the afﬁnity for
ssDNA, just as it does when the C-terminus is deleted from phage and
bacterial SSBs.
Fig. 3. Electrophoretic mobility shift analysis of VACV and MCV DNA–protein
complexes. Each reaction mix contained 1 mg of single-stranded ϕX174 DNA and 0–
15 mg of the indicated proteins. The mixtures were incubated at 37 °C for 20 min,
fractionated by electrophoresis through a 0.8% agarose gel, stained, and the DNA
visualized using ultraviolet light. The native proteins form complexes that migrate
more slowly as the amount of protein is increased in each reaction. One difference
between the VACV and MCV proteins is apparent at the highest protein con-
centrations, where the native MCV protein promoted some formation of high-
molecular weight DNA aggregates, which were retained in the wells. Deleting the
C-terminal tails from both of the VACV and MCV SSBs creates proteins that greatly
exacerbates the tendency to aggregate ϕX174 DNA. This is illustrated by the
quantities of DNA trapped in the wells (arrowed).
Fig. 4. Electrophoretic mobility shift analysis of DNA–protein complexes containing
mixtures of wild-type and truncated I3 protein. Each reaction contained 1 mg of
single-stranded ϕX174 DNA and 5 mg (total) of full-length I31–270 plus truncated
I31–244 proteins. The proportion of each protein was varied in steps of 10% across
the sample spectrum, starting with 100% I31–270 plus 0% I31–244. The mixtures were
incubated at 37 °C for 20 min, fractionated by electrophoresis through a 0.8%
agarose gel, stained, and the DNA visualized using ultraviolet light. Adding I31–244
caused a progressive increase in the migration rate of the DNA–protein complexes
until the proportion of the mutant protein began to exceed 50% of the I3 in the
reaction. At that point protein–DNA aggregates, resembling those formed in reac-
tions containing just the mutant protein, began to be formed and trapped in the
wells (arrow). The starred reaction (*) contained only ϕX174 DNA.
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the structure of the protein–DNA complexes
Electrophoretic mobility shift assays were used to see what
effect these alterations had on the structures of complexes formed
by wild-type and mutant poxvirus SSBs. Single-stranded circular
ϕX174 DNA was bound to different quantities of each of the SSBs
in a low ionic strength buffer (50 mM NaCl) and then the DNA–
protein complexes were size fractionated using agarose gel elec-
trophoresis and visualized with a DNA stain. As one would predict,
all of the proteins progressively decreased the rate of migration of
the DNA as the protein-to-DNA ratio was increased (Fig. 3). At
higher protein amounts the intact I31–270 form still bound the
DNA, and all DNA entered the gel, whereas the truncated I31–244
form trapped the DNA in the wells in high-molecular aggregates
(Fig. 3, arrows). A similar effect was seen with the MCV proteins
although the wild-type 0461–280 species exhibited some natural
tendency to form aggregates at the highest concentrations tested.
This property was greatly exacerbated when the C-terminus was
deleted in form 0461–285 (Fig. 3, arrows). These data suggest that
the structures of the complexes formed by SSBs lacking the C-
terminal tail are quite different from normal complexes. Moreover,
the propensity of the mutant proteins to form such aggregates
could be a factor contributing to the higher observed DNA binding
afﬁnity (Fig. 2).We also investigated what effect mixing the wild-type and
mutant VACV proteins together would have on these gel-shifted
complexes. To detect the anomalous structures that are char-
acteristic of those formed by I31–244, we used a DNA–protein ratio
that can generate well-bound aggregates (Fig. 3). As the propor-
tion of the truncated I31–244 form was increased relative to the
wild-type protein, it caused a gradual increase in the electro-
phoretic mobility of the DNA–protein complexes (Fig. 4). However,
as the ratio of the two proteins started to exceed 50%, the aggre-
gated form again appeared. Thus the mutant has the capacity to
interfere with normal protein activity and might be expected to
exhibit a dominant negative phenotype in virus-infected cells. This
point is explored further below.
The VACV-I3 C-terminal tail is accessible for binding to other proteins
in DNA–protein complexes
We next examined whether the I3 C-terminus would be
exposed for binding to other potential protein partners upon DNA
binding. To test this hypothesis, we took advantage of the obser-
vation that our 10D11 monoclonal anti-I3 antibody reacts very
well with the I31–270 protein, but cannot detect the I31–244 form
(Fig. 1C). It also detects a C-terminal histidine-tagged form of I3 in
western blots (data not shown). This indicates that that antibody
10D11 recognizes an internal epitope within the I3 C-terminus. We
then used a gel “supershift” analysis to determine whether the C-
terminal epitope can be detected in DNA–protein complexes. To
perform the experiment we assembled DNA–protein complexes
composed of ϕX174 DNA plus 1–2.5 mg of I31–270 or I31–244. We
then incubated these complexes with up to a 5-fold molar excess
of the 10D11 antibody or an isotope control antibody targeting
VACV E9 protein. The products were size fractionated using gel
electrophoresis (Fig. 5). The I3-speciﬁc antibody selectively
supershifted the I31–270-DNA complexes relative to the shift
observed with just I3 added alone, and in a manner dependent
upon both I3 and antibody concentration (Fig. 5A). This large shift
was not observed when the I3-speciﬁc antibody was added to
complexes composed of DNA plus the I31–244 protein (Fig. 5B),
Fig. 5. Electrophoretic mobility shift analysis of DNA–protein complexes formed in
the presence of antibodies that recognize the C-terminus of VACV I3 protein. Each
ﬁnal reaction contained 1 μg ΦX174 DNA, the indicated quantities of I31–270 or I31–
244, and the indicated amounts of monoclonal antibodies recognizing either I3
(upper panels) or an unrelated protein (VACV E9, lower panels). The I3 antibody
complexes were formed for 20 min at 37 °C, ΦX174 DNA was added, and incubated
for another 20 min at 37 °C. The products were fractionated by electrophoresis
through a 0.8% agarose gel, stained, and the DNA visualized using ultraviolet light.
Lane “0” in each panel contained ΦX174 DNA and the highest quantity of antibody
(275 mg), but no I3.
Fig. 6. Multi-angle laser light scattering (MALLS) analysis of I3-containing protein–
protein and DNA–protein complexes. Panel A. Puriﬁed I31–270 protein was size
fractionated on a Superose 6 column in a buffer containing 0.15 M NaCl and the
eluting proteins detected by the change in the refractive index. The mid-point in
the elution curve contains protein complexes with a molecular weight of 38 kDa as
judged by an in-line laser light scattering detector. Panel B. The I31–270 protein seen
in Panel A was recovered, concentrated, mixed with dT30 (at a 1:1 mol ratio) and
rechromatographed. Two types of complexes can be detected exhibiting molecular
weights of 134 and 61 kDa. Panel C. Puriﬁed I31–244 protein was analyzed as in Panel
A. I3 lacking the C-terminal tail exhibit a solution molecular weight of 30.8 kDa as
judged by MALLS. Panel D. The I31–244 protein was recovered, mixed with dT30, and
rechromatographed as in Panel B. A single complex with a molecular weight of
118 kDa was detected.
M.L. Harrison et al. / Virology 489 (2016) 212–222216although some background of non-speciﬁc binding was detected
that was comparable to that seen in reactions containing added E9
control antibody (Fig. 5, panels C and D). Some antibody-
dependent aggregation of the DNA–protein complexes was also
seen, but only in reactions containing the 10D11 antibody and
wild-type I3. These studies showed that the VACV I3 C-terminus is
accessible for binding to other proteins in DNA–protein complexes.
The C terminal tail of I3 alters the stability of both I3:I3 and I3:DNA
interactions
To gain some insights into the nature of the DNA–protein com-
plexes formed by I31–270 and I31–244 proteins, we used gel ﬁltration
in combination with multi-angle laser light scattering analysis.
Multi-angle light scattering methods are often used to measure the
size of protein complexes and rest upon theoretical foundations
established by Stokes and Svedberg. The method can determine the
mass of macromolecular complexes to an accuracy approaching
73%. One can gain insights into the composition of such complexes
by testing the ﬁt between an observed mass and a hypothetical
mass obtained by adding together different possible combinationsof masses of components of known molecular weights. The puriﬁed
I3 proteins were initially applied to a Superose 6 column connected
to a Wyatt Systems instrument operating in isocratic mode, in a
buffer containing 0.15 M NaCl, and the molecular weight of the
eluting proteins determined using ASTRA software. This ionic
strength reﬂects biologically relevant salt conditions while still
favouring DNA binding (Fig. 2). These proteins were then recovered,
concentrated, incubated with a 1:1 mol ratio of 30-mer poly-dT
oligonucleotide (Tseng et al., 1999), and reapplied to the system.
Under these conditions I31–270 eluted as a single peak with a
molecular weight of 3871 kDa (Fig. 6A). When bound to dT30, I31–
270 produced two elution peaks, the ﬁrst exhibiting a molecular
weight of 13475 kDa and the second at 6175 kDa (Fig. 6B). The
behavior of the DNA-free protein is difﬁcult to reconcile with it
being either a monomer (30.0 kDa) or a stable dimer (60.0 kDa),
and is suggestive of a protein exchanging rapidly between these
states during chromatography. The mass of the larger species
formed in the presence of 9.1 kDa dT30 molecules is most compa-
tible with an I3 tetramer bound to one molecule of dT30 (129 kDa)
whereas the smaller species exhibits a size closely predicted for a
protein dimer (60.0 kDa) or possibly a dimer plus DNA (69.1 kDa).
Deleting the I3 C-terminal tail signiﬁcantly altered the behavior of
the protein and the complexes it forms. The pure protein exhibited
Fig. 7. Microinjection of anti-I3 monoclonal antibodies into virus-infected cells. BSC-40 cells were injected with 5 mg/ml solutions of monoclonal antibodies recognizing
either I3 (10D11, lower panels) or an unrelated protein (a hexahistidine epitope, upper panels) and then infected with VACV at a multiplicity of infection of 5. The cells were
ﬁxed 6 h later, stained as indicated, and imaged. The DNA-containing cytoplasmic structures are virus factories, these are sites of virus replication and contain all of the I3
antigen.
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plus ssDNA produced a single species with a mass of 11870.1 kDa
(Fig. 6D). The former is most likely a protein monomer (27 kDa) and
the latter closely matches the mass predicted for a tetramer with a
single molecule of dT30 (117 kDa). These data suggest that the C-
terminus modulates the stability of I3–I3 and I3-DNA complexes
and, one interpretation that is consistent with the data, would be
that the C-terminus partly stabilizes protein dimers, but somewhat
destabilizes single-strand DNA binding.
Microinjection of anti-I3 antibodies in VACV-infected cells decreases
the size of viral factories
Although these studies suggested that the I3 C-terminus regulates
the structures of I3-DNA complexes, they provide no insights into
whether these observations have any relevance to virus biology. The
I3L gene is essential, and has proven difﬁcult to mutate (Greseth et
al., 2012), and so using a genetic approach was unlikely to be pro-
ductive. Indeed, our repeated efforts to rescue a second gene
encoding the I31–244 allele into a pure recombinant I3Lþ virus failed
(data not shown). Instead, we tested whether the 10D11 monoclonal
antibody, which targets the C-terminal epitope in DNA–protein
complexes (Fig. 5), would have any effects on VACV replication in
cells injected with the antibody. This can be easily assayed, because
replicating poxviruses produce characteristic structures in the cyto-
plasm of infected cells (Fig. 7). These factories can be stained with
DAPI and the amount of virus DNA quantitated using ﬂuorescence
microscopy. BSC-40 cells were microinjected with the 10D11 anti-
body (or with an anti-hexahistidine isotype control antibody) and
then infected with VACV at a multiplicity of infection of ﬁve. The cells
were cultured for 6 h, ﬁxed and stained with a Cy5 labeled 2° anti-
body, and counterstained to detect DNA and actin. The cells were
then imaged and the size and the ﬂuorescent intensity of the fac-
tories determined using Volocity software. The results are shown in
Figs. 7 and 8. The control (anti-hexahistidine) antibody was dis-
tributed throughout the cytoplasm of infected cells, whereas the I3
antibody speciﬁcally stained virus factories as we showed previously
(Lin et al., 2008). Although virus factories were still present in cellsinjected with the 10D11 antibody (Fig. 7), careful measurement of
either the size (Fig. 8A) or the ﬂuorescence intensity (Fig. 8B)
demonstrated that they were signiﬁcantly smaller than the factories
formed in either buffer-injected cells (p¼0.001) or anti-
hexahistidine-injected cells (po0.0001) (Fig. 7). However, the dif-
ference was not large; the factories in anti-I3-treated cells were only
about 2-fold smaller than the factories in the control cells.
We also repeated these experiments using cells micro-injected
with 5 mg/ml N30-mer or S30-mer peptides. Both appeared to be
inhibitory compared to buffer-injected control cells (po0.05)
although again the magnitude of the effect was very limited (data
not shown). Nevertheless these experiments showed that inter-
fering with processes involving the I3 C-terminus has deleterious
effects on virus DNA replication.
I3 does not interact with the small (R2) subunit of VACV during virus
infection
There have been at least two reports that I3 can bind to other
protein partners [besides itself (McCraith et al., 2000)]. These include
eIF4G (Zaborowska et al., 2012) as well as the small (R2) subunit of
VACV ribonucleotide reductase (Davis and Mathews, 1993). The VACV
F4L gene encodes the R2 protein, and the later paper is of particular
interest since the F4-I3 interaction has been proposed to involve the I3
acidic C-terminus (Davis and Mathews, 1993). Thus by disrupting such
an interaction, one could perhaps explain the result shown in Fig. 8. To
explore this matter further, we prepared a plasmid encoding an N-
terminal Flag-tagged form of I3 under control of a VACV promoter and
transfected the plasmid into VACV-infected BSC-40 cells. The infected-
cell proteins were then retrieved using anti-Flag magnet beads and
fractionated using SDS-PAGE. For controls we either omitted the VACV
or transfected the infected cells with an empty (pSC66) vector. Some
of the gels were stained to detect total protein, while others were
Western blotted using antibodies directed against the cellular and
viral ribonucleotide reductase R1 and R2 subunits. Although the
reagents can readily detect the VACV F4 (R2) and I4 (R1) proteins in
cell-free extracts, and can also retrieve Flag-tagged I3 from the
transfected extracts (Fig. 9A), we were never able to detect an
Fig. 8. Effect of monoclonal antibodies, targeting I3, on the size of VACV factories.
Cells were microinjected with monoclonal antibodies recognizing the I3 protein or
a control hexahistidine epitope, infected with VACV for 6 h, and processed and
imaged as illustrated in Fig. 7. Volocity software was used to determine the size
(Panel A) and intensity (Panel B) of the different DAPI-stained factories in 30 cells
per treatment group, and Student's t-tests were performed to determine the sta-
tistical signiﬁcance of any differences. Cells injected with the antibody against I3
contained the smallest factories whether compared against control cells injected
with the buffer only, or with an anti-hexahistidine monoclonal antibody.
Fig. 9. Analysis of proteins associated with VACV I3 protein. Panel A. BSC-40 cells
were infected (lanes 1–2) or mock infected (lane 3) with VACV and transfected with
either the empty vector (lanes 2) or a plasmid bearing an N-terminal Flag-encoding
form of I3L under control of a poxvirus early/late promoter (lanes 1 and 3). The cells
were cultured for 24 h and the N-Flag-tagged I3 recovered using anti-Flag anti-
bodies cross-linked to magnetic beads. The bound proteins were then size frac-
tionated using SDS-PAGE and processed by western blotting to detect the VACV
ribonucleotide reductase subunits (encoded by the I4L and F4L genes) or the Flag-
tagged and native forms of I3. Panel B. Immunoﬂuorescence analysis of the dis-
tribution of the VACV F4 protein in VACV-infected cells. BSC-40 cells were infected
(or mock-infected) with the indicated viruses and then ﬁxed and stained to detect
DNA, I3, and a his6-tagged form of F4. Note that the ΔF4L mutation retards virus
replication. As a consequence the factories are smaller and more compact than in
cells infected with virus encoding wild type or his6-tagged F4.
M.L. Harrison et al. / Virology 489 (2016) 212–222218interaction between Flag-tagged I3 and either of the proteins com-
prising the VACV ribonucleotide reductase complex (Fig. 9A). As an
alternative approach we hypothesized that if I3 can interact with F4, it
should recruit at least some F4 to the sites of virus replication where
I3 is found. We used immunoﬂuorescence microscopy to map the I3
and a his6-tagged form of F4 (Gammon et al., 2010) in VACV-infected
cells and as a control used a virus bearing a ΔF4L deletion to docu-
ment the speciﬁcity of the hexahistidine-speciﬁc antibody (Fig. 9B).
The ΔF4L virus is easily differentiated from F4Lþ viruses since it
replicates more slowly and makes smaller factories. In these VACV
ΔF4L infected cells, the his6-speciﬁc antibody detected only a thinlydistributed background staining resembling that seen in mock-
infected cells. In contrast, this antibody detected a much more
intense signal in cells infected with virus expressing his6-tagged F4.
The his6-tagged F4 was widely distributed throughout the cells, while
I3 was uniquely located in the DAPI-stained virus factories. We also
determined the Pearson coefﬁcient of correlation, testing how often
red (I3) and green (his6-F4) pixels overlapped, and observed values
varying from r¼0.07 to r¼0.16, providing little support for there
being any clear co-localization of the two antigens in infected cells.
Although we cannot preclude the possibility that the I3 acidic tail
serves some role as a protein-binding site, our data mostly support the
hypothesis that its primary function is to modulate the structure of I3-
DNA complexes in infected cells.
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Although I3-like genes are found only in poxviruses, they share
a common acidic C-terminal tail with some bacterial and phage
counterparts (Fig. 1). This protein element plays an important role
in regulating ssDNA binding as well as helping recruit DNA repli-
cation, recombination and repair proteins to sites where the
ssDNA is exposed. The purpose of this study was to examine
whether two exemplars of these poxvirus SSBs, cloned from two
different Chordopoxviruses (MCV and VACV) exhibit properties
similar to these phage and bacterial SSBs.
Protease sensitivity is a characteristic feature of these SSB
acidic tails and we had previously noted that the C-terminus of
VACV I3 protein is similarly protease sensitive (Tseng, 2000).
Trypsin rapidly excises a 25 aa peptide comprising most of I3's
acidic C-terminus, although a 30-residue patch extending towards
the N-terminus and highly-conserved EED, DDD, or EEE motifs
probably better deﬁnes the boundaries of this element (Fig. 1).
Computational modeling of this 30-mer (Neron et al., 2009) sug-
gests that the central acidic portion would likely fold into an α-
helix with an unstructured C-terminus. This peptide also clearly
encodes the epitope recognized by the 10D11 monoclonal anti-
body (Fig. 1C). However, we have not screened other I3 antibodies
so it is difﬁcult to say whether this is just a coincidence, or because
the I3 C-terminus, like the T4 GP32 C-terminus (Krassa et al.,
1991), is an immunodominant epitope.
Further parallels between the virus and phage SSBs are
observed when one deletes the acidic tails from the VACV and
MCV proteins. The recombinant proteins still appeared to retain
their native structure judging by the solubility and afﬁnity for
DNA. However, these alterations clearly increased the afﬁnity of
the virus I31–244 and 0461–265 proteins for ssDNA, relative to the
native forms (Fig. 2). Although it seems counterintuitive that
mutant proteins would have a higher afﬁnity for DNA, the effect is
explained by previous models, in which the C-terminal tail com-
petes with the ssDNA for protein binding sites, and deleting these
peptides enhances DNA-binding. While the mutant forms of the
VACV and MCV proteins can bind strongly to ssDNA, it is also clear
they do not assemble into the same kinds of complexes formed by
the native proteins, as judged by agarose gel shift experiments
(Fig. 3). At lower protein amounts the native complexes migrated
more slowly than do those formed by proteins lacking the C-
termini and, since they are not expected to have bound less pro-
tein, this is best explained if the native complexes exhibit a greater
hydrodynamic radius. Moreover, at higher protein amounts, the
proteins lacking the C-terminus aggregated DNA, which then did
not enter the gels during electrophoresis (Fig. 3, arrowed). This
behavior of the I31–244 form was also seen when the mutant
protein was added in increasing proportions to the wild-type
protein, at a biochemical level it is a dominant trait (Fig. 4).
This property of the mutant protein is interesting considering
that, despite repeated tries, we were never able to produce a VACV
encoding copies of both the wild-type and mutant proteins (data
not shown). This could be explained in various ways, but if it is
assumed that viral DNA replication would be inhibited by abnor-
mal DNA structures, then trying to express the I31–244 form might
be doomed to failure due to I3L being essential and the mutant
gene exhibiting properties characteristic of a dominant negative
mutation.
The data shown in Fig. 5 also illustrates additional similarities
between phage and poxvirus SSBs. DNA binding still leaves the C-
terminal epitope sufﬁciently exposed that it can be bound by a
monoclonal antibody (Fig. 5). These observations further support
the hypothesis that the I3 C-terminus shares part of the same
binding site as does DNA and it is not appreciably occluded in
DNA-containing complexes. Parenthetically, the fact that the10D11 antibody targets an exposed epitope encoded by one of the
most highly translated VACV early mRNAs (Yang et al., 2015),
explains why many laboratories have found it a very useful reagent
for imaging factories (Liu et al., 2015; McFadden et al., 2012;
Zaborowska et al., 2012).
The I3 C-terminus also appears to play a key role in organizing
the structure of smaller-scale I3-DNA complexes. Using Sephacryl
S100 gel exclusion chromatography, Greseth et al. (2012) observed
that most of their his6-tagged and DNA-free I3 exhibited the same
hydrodynamic dimensions as ovalbumin (44 kDa) with small
amounts of high-molecular-weight complexes or protein aggre-
gates also eluting near the void volume. This is consistent with our
data. Although MALLS measures both the hydrodynamic shape
and molecular weight of proteins, the protein Greseth et al. saw
co-eluting with ovalbumin is most likely DNA-free I3 undergoing
rapid monomer-dimer exchange (Fig. 6). In the presence of ssDNA,
native I3 is recruited into larger complexes, which exhibit masses
compatible with a molecule of DNA in stable association with 2 or
4 molecules of I3. Interestingly, deleting the C-terminus appeared
to disrupt the monomer-dimer equilibrium (Fig. 6), and stabilized
a tetrameric DNA protein complex.
The MALLS (Fig. 6) and gel shift data (Fig. 3) collectively suggest
a model in which the acidic tails serve at least two important
functions. First, they may promote cooperative binding of I3 to
DNA through a swapped dimer interaction. This would minimize
the risk of forming inter-strand links between SSB monomers that
have initially bound randomly to different sites in the substrate.
Secondly, the C-terminal tails may destabilize the DNA–protein
complexes enough to permit sliding of these structures (perhaps
as dimers) along the DNA. This would ensure that the SSB mole-
cules are distributed properly along the length of the substrate, in
the process generating a more open and accessible structure. In
the absence of these tails, the SSB molecules would likely bind
randomly to many different and relatively stable sites in the DNA.
Collectively this random binding of truncated proteins to DNA sites
scattered across many different molecules, proteins still capable of
forming tetramers in the presence of DNA (Fig. 6), could produce
interstrand crosslinks and the aggregates seen in Fig. 3.
I3 is an essential protein and interfering with its expression and
with I3–I3 interactions has deleterious effects on virus replication
(Gammon et al., 2010; Greseth et al., 2012). Thus, one would
predict that if the I3 C-terminus modulated I3 function in vivo,
interfering with this function might lead to a decrease in the
amount of virus DNA replication. To examine this question we
microinjected the 10D11 anti-I3 antibody into VACV-infected cells
and used DAPI staining to measure the amount of DNA in virus
factories 6 h post-infection. The microinjected 10D11 antibody co-
localized with VACV factories and caused a 2-fold decrease in
virus replication compared to an isotype control (Fig. 8). One dif-
ﬁculty with this experiment is that concentrations and volumes
limit how much antibody can be microinjected into a cell, and it
may be difﬁcult to occlude all of the potential target sites. Quan-
titative western blotting suggests that I3 protein is expressed at
very high levels in VACV-infected cells, with perhaps 109
molecules per cell by 6 h post-infection (data not shown), and this
qualitative observation is in agreement with data obtained, from
ribosome proﬁling (Yang et al., 2015), concluding that I3 is a highly
expressed protein. Conversely, it is difﬁcult to introduce much
more than 106 molecules of antibody by microinjection, so
except at early times in the infection, I3 will usually be present in
excess over antibody. The fact that one still sees a small but sig-
niﬁcant decrease in the amount of DNA in cells injected with the
10D11 antibody, even under these circumstances, suggests that the
I3 C-terminus is accessible in vivo and that blocking (or perhaps
crosslinking) the protein through the C-terminus can inhibit early
virus DNA replication in vivo.
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been able to detect any speciﬁc binding of other proteins to the C-
terminus (Fig. 9A). It has been hypothesized that I3 interacts with
the small F4L-encoded subunit of the VACV ribonucleotide
reductase (Davis and Mathews, 1993), but we could not detect this
using co-immunoprecipitation reactions and antibodies directed
against Flag-tagged I3 and native F4. Although it is possible that an
I3–F4 interaction is too unstable to be detected by these methods,
we also could not detect any selective recruitment of F4 to the
factories where I3 is found (Fig. 9B). Collectively these data argue
against the hypothesis that I3 is used to recruit signiﬁcant
amounts of the VACV ribonucleotide reductase to sites of viral
DNA replication. The I3 tail is clearly exposed in I3-DNA complexes
and could still recruit other proteins to sites of replication. How-
ever, we favor the hypothesis that the primary function of the I3
tail is to promote the formation of well ordered, and yet still only
meta-stable, I3-DNA complexes. The observation that one can
transfect DNA encoding an mCherry reporter gene fused to the I3
C-terminus, and detect seemingly normal protein localization in
normal virus factories (Greseth et al., 2012) also supports the
hypothesis that I3 function is still preserved even if the C-terminus
is occluded by something as large as the mCherry protein.
Although this work has focused primarily on the VACV I3
protein, the 046 homolog encoded by MCV also exhibits many of
the same basic properties. MCV differs greatly from VACV, in
particular the MCV genome is very GþC-rich and MCV lacks so
many of the genes encoded by most other poxviruses (including
the thymidine kinase and ribonucleotide reductase) that MCV only
replicates slowly in vivo and cannot be cultured in the laboratory.
Nevertheless, deleting the C-terminus of the MCV 046 protein
enhances the afﬁnity for ssDNA and causes the mutant protein to
form complexes that exhibit the same altered migration properties
as the truncated I3 protein. These data suggest that the bio-
chemical properties of I3 and 046 are probably shared by all
poxvirus SSBs, and that the model we have proposed for coop-
erative recruitment and I3-DNA interactions is likely applicable to
all of the Chordopoxvirus SSBs. What remains to be established is
how the I3 C-terminus affects the recruitment of I3 onto ssDNA
and how this process affects the global structure of larger DNA–
protein complexes.Materials and methods
Viruses, cell culture, and reagents
VACV A5L-YFP was obtained from Dr. B. Moss (National Institute
of Allergy and Infectious Diseases) (Katsafanas and Moss, 2007). A
VACV strain encoding a deletion of the F4L locus (ΔF4L) and a strain
encoding a functional his6-tagged form of the encoded ribonu-
cleotide reductase R2 protein (ΔF4L/ΔJ2RHisF4L) were constructed
previously (Gammon et al., 2010). VACV strain Western Reserve
(WR) was acquired from the American Type Culture Collection as
well as African green monkey kidney cells (BSC-40). E. coli strain
DHE142 was constructed in this laboratory (Zhang and Evans, 1995)
and strain DH10B was purchased from Invitrogen as competent
cells. BSC-40 cells were cultured in modiﬁed Eagle's medium
(MEM) supplemented with 5% fetal bovine serum (FBS). Single-
stranded ϕX174 phage DNA was purchased from New England
Biolabs and oligonucleotides from Integrated DNA Technologies. A
plasmid encoding the molluscum contagiosum virus (MCV) MC046L
gene (locus NP_043997) was purchased from GeneArt.Molecular cloning
The polymerase chain reaction was used to prepare a full-length
copy of the I3L gene [encoding I3 residues 1–270 (I31–270)] using a
VACV DNA template and forward (50-CTTTAAGAAGGAGATATACA-
TATGAGTAAGGTAATCAAGAAGAG-30) and reverse (50- CTTTGTTAG-
CAGCCGGATCCTTATAGATTGAATATTGGCTTTTCT-30) primers. A C-
terminal truncated form of I3L (I31–244) was prepared using the
same forward primer and the reverse primer 50-CTTTGTTAG-
CAGCCGGATCCTTAAGCCAGATCTTCTTCTACAT-30. A full-length copy
of the MCV MC046L gene (0461–288) was prepared using a
plasmid template encoding a cloned and codon-opti-
mized copy of the gene and forward (50-CTTTAAGAAGGAGATATA-
CATATGCGTAAAGCAGTTCCGGGTAAAC-30) and reverse (50-
CTTTGTTAGCAGCCGGATCCTTACACATTAAACAGCGGGTCCTGATC-30)
primers. A C-terminal truncated form of the MCV MC046L gene
(0461–265) was prepared using the same MC046L forward pri-
mer and reverse primer 50-CTTTGTTAGCAGCCGGATCCTTACA-
GACGTTCATCATCATCTGCGC-30. The PCR products were cloned into
pET11a (Novagen) using InFusion enzyme (Clontech), used to
transform E. coli DH10B, and recombinant clones sequenced. The
plasmids were then used to transform E. coli strain DHE142 for
purposes of protein expression.
To make a Flag-tagged form of I31–270 we used a two-step process.
First the PCR, a VACV DNA template and forward (50-GTCGA-
CATGGACTACAAGGACGACGATGACAAGATGAGTAAGGTAATCAAGAAGA-
GAG-30) and reverse (50-GCGGCCGCTTATACATTGAATATTGGCTTTTC-30)
primers were used to amplify a copy of the I3 gene and incorporate a
Flag-tag-encoding sequence at the start of the gene. The PCR product
was TOPO-cloned (Invitrogen) and then recloned into pSC66 under a
virus early-late promoter.
Protein puriﬁcation
Bacteria were cultured at 37 °C in 7.5 L quantities of Luria broth
with 100 mg/ml ampicillin (Fisher) and 25 mg/ml chloramphenicol
(ICN Biomedicals). Protein expression was induced by adding
1 mM isopropyl β-D-α-thiogalactopyranoside (Fisher) followed by
the addition of 50 mg/ml rifampicin (Sigma). The cells were
recovered by centrifugation, resuspended in Buffer A [0.2 M
Tris HCl pH 7.8 (MP Biomedicals), 0.1 mM EDTA pH 8.0 (Sigma),
10 mM β-mercaptoethanol (Sigma), 10% glycerol (Sigma), 50 mM
NaCl (Fisher)] and stored frozen at 20 °C. The cells were thawed
and sonicated, centrifuged at 20,000g for 30 min and the pellet re-
extracted by sonication and centrifugation. The pooled super-
natents were applied to a 5 ml HiTrap Heparin HP column (GE
Healthcare), washed with Buffer A, and eluted in a stepwise
manner using Buffer A supplemented with 0.1–2.0 M NaCl.
Protein-containing fractions were dialyzed against Buffer A, and
applied to a 10 ml column of single-stranded calf thymus DNA
cellulose (Sigma). The column was washed with Buffer A and the
protein eluted with Buffer A containing 0.5 M or 2.0 M NaCl.
Protein-containing fractions were dialyzed against Buffer A, con-
centrated using a 5 ml heparin column (which also removes any
residual DNA), and stored at 80 °C.
Protein electrophoresis and western blotting
Sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS PAGE) and a commercial Coomassie stain (Pierce) were used
to determine protein purity. Immobilon FL membranes (Millipore)
were used for western blotting. A mouse monoclonal antibody
directed against the I3 protein (clone 10D11) prepared by ProSci
(Lin et al., 2008) as were monoclonal antibodies directed against
the VACV F4 protein (clone 4B3) (Gammon et al., 2010) and the E9
protein (clone 4E5) (Magee et al., 2009). All three are IgG1
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nucleotide reductase R1 subunit antibody (Chemicon), a goat anti-
cellular ribonucleotide reductase R2 subunit antibody (N-18; Santa
Cruz), a mouse anti-Flag antibody (M2; Sigma), and a mouse
monoclonal anti-hexahistidine antibody (Roche). Dr. C. Mathews
(Oregon State University) kindly provided a rabbit anti-VACV I4
antibody (Slabaugh et al., 1993). Blots were imaged using a LI-COR
Odyssey imager and a LI-COR anti-mouse antibody labeled with an
800 CW IR-Dye, or anti-goat and anti-rabbit antibodies labeled
with IR-Dye 680.
To determine the amount of I3 in VACV-infected cells, BSC-40
cells were infected for 6 h at a multiplicity of infection of ﬁve, and
then harvested and known numbers of cells lysed and applied to
an SDS-PAGE gel along with known amounts of recombinant I31–
270. The quantity of I3 per cell was then determined using LI-COR
software and the computed standard curve.
Electrophoretic mobility shift assays (EMSA)
Each SSB was incubated with 1 mg of ϕX174 ssDNA for 20 min
at 37 °C in a 20 ml reaction containing 12 mM Tris HCl pH 8.0, 2.4%
glycerol, 1 mM EDTA, and 2.5 mM β-mercaptoethanol. Two
microliters of loading buffer (50 mM Tris HCl pH 7.5, 0.6% glycerol)
was added to each sample, and the DNA–protein complexes frac-
tionated by gel electrophoresis using gels composed of 0.8% Sea-
kem LE agarose (Lonza) and run at 30 V for 17 h at 4 °C in half-
strength Tris-acetate buffer. The DNA was stained with Sybr Safe
dye (Invitrogen) and imaged. The same methods were used to
perform antibody EMSA supershift studies, except that the SSB
was bound to the ssDNA for 20 min at 37 °C and then monoclonal
antibodies directed against VACV I3 or E9 proteins were added,
and incubated for another 20 min at 37 °C, followed by electro-
phoresis and imaging.
DNA cellulose binding assay
A 1 ml slurry was prepared containing 50% (w/v) of single-
strand calf thymus DNA cellulose and 0.6 mg of SSB in Buffer A.
The mix was gently mixed by rotation for 1 h at room temperature
and then centrifuged for 1 min at 1000g. The supernatant was
recovered and the protein was progressively eluted from the DNA
by stepwise addition of 0.5 ml of Buffer A containing increasing
concentrations of NaCl (0.05–3.0 M), followed at each step by
mixing and centrifugation. The eluted proteins were fractionated
using SDS PAGE gels and stained with a Coomassie blue stain (10%
phosphoric acid, 0.8 M ammonium sulfate, 0.0012% Coomassie
Brilliant Blue G-250, 20% methanol). A BioRad Gel Doc system and
Image Lab software were used to determine the quantity of pro-
tein eluted in each fraction.
Multi-angle laser light scattering (MALLS)
Bovine serum albumin (BSA), I31–270, or I31–244 were chroma-
tographed on a Superdex 200 10/300 GL column (GE Healthcare)
equilibrated with Buffer A containing 150 mM NaCl. Peak fractions
were pooled and concentrated using Amicon Ultra 10K Ultracel
ﬁlters (Millipore). An aliquot of each protein (0.6 mg in 100 ml)
was then applied to a Superose 6 10/300 GL column (GE Health-
care) equilibrated with Buffer A containing 150 mM NaCl and
connected to a Wyatt Systems REX and DAWN MALLS. Changes in
refractive index were used to detect eluting proteins and the data
analyzed using ASTRA software. The I31–270 and I31–244 proteins
were collected as they eluted, mixed with 30-mer poly-dT oligo-
nucleotide in a 1:1 mol ratio, incubated for 30 min at 37 °C and
re-applied.Microinjection and ﬂuorescence microscopy
BSC-40 cells were cultured overnight on coverslips in MEM and
then injected with a mouse monoclonal antibody directed against I3,
or an anti-hexhistidine isotype control antibody (Roche), using an
Eppendorf FemtoJet microinjector system. The antibodies were pre-
pared at 5 mg/ml in buffer containing 0.1 M glutamic acid (Fisher),
0.14 M KOH (Acros), 1 mM MgSO4 (Acros), 1 mM dithiothreitol
(Fisher), adjusted to pH 7.2 with citric acid (Acros). We used duplicate
coverslips, injecting 250 cells per coverslip. The cells were then
infected for 1 h at 37 °C with A5L-YFP VACV, at a multiplicity of
infection of 5 in PBS, the buffer was replaced with MEM, and
returned to the incubator for 5 h. The cells were then ﬁxed in PBS on
ice in 4% paraformaldehyde for 30 min, stained with 1:2000 diluted
Cy5-labeled secondary antibody and counterstained with 10 ng/ml
40,6-diamidino-2-phenylindole (DAPI) and 1 nM rhodamine phalloi-
din as per the supplier's instructions (Molecular Probes). The samples
were imaged using a Quorum WaveFX spinning disk confocal
microscope and analyzed using Volocity software (Perkin-Elmer).
Student's t-test was used to compare differences in mean area,
po0.05 was considered signiﬁcant.
For ordinary ﬂuorescence microscopy, samples were ﬁxed and
stained as described previously (Lin and Evans, 2010), imaged
using an Applied Precision DeltaVision ﬂuorescence microscope,
and processed using the deconvolution algorithm supplied with
softWoRx (v3.7). Photoshop CS6 was used to prepare composite
images. All of the images were subjected to the same scaling and
background corrections using only a linear gamma factor.Immunoprecipitation
BSC-40 cells were infected for 1 h with VACV at a multiplicity of
infection of 5 in PBS in 150mm dishes. The virus was then removed
and replaced with Opti-MEM (Gibco). One hour later (2 h post-
infection), the cells were transfected with 8 mg of plasmid encoding
an N-terminal Flag-tagged form of I3 (N-ﬂag I31–270) using Lipo-
fectamine (Invitrogen). The cells were cultured overnight, harvested,
washed with PBS, and lysed by passage through a 21.5 gauge needle
in 0.5 ml lysis buffer [0.15 M NaCl, 20 mM Tris HCl pH 8, 1 mM EDTA,
0.5% NP-40 (Fisher)] supplemented with one protease-inhibitor tablet
per 20 ml buffer (Roche). The lysate (500 ml) was supplemented
with 10 mg of a 30-mer poly-dT oligonucleotide, incubated on ice for
1 h, and then mixed with 50 mL of a 50% slurry of mouse monoclonal
anti-Flag magnetic beads (Sigma). The mixture was nutated overnight
at 4 °C and then the beads were recovered and washed with buffer
containing 50 mM Tris HCl pH 7.4 and 150 mMNaCl. The beads were
boiled in loading buffer (3.7% SDS, 0.6 M β-mercaptoethanol, 40%
glycerol, 50 mM Tris HCl pH 6.8, 1 mg/mL bromophenol blue) and
the proteins fractionated on SDS PAGE gels prior to staining or wes-
tern blotting as described above.Acknowledgments
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